Found: 22
Select item for more details and to access through your institution.
Structure and Reactivity of an Asymmetric Synthetic Mimic of Nitrogenase Cofactor.
- Published in:
- Angewandte Chemie, 2016, v. 128, n. 50, p. 15862, doi. 10.1002/ange.201608806
- By:
- Publication type:
- Article
A single-institution retrospective exploratory analysis on the effectiveness and safety of lenvatinib plus pembrolizumab for advanced endometrial cancer: insights from ProMisE molecular classification system.
- Published in:
- Japanese Journal of Clinical Oncology, 2024, v. 54, n. 4, p. 424, doi. 10.1093/jjco/hyad192
- By:
- Publication type:
- Article
Structure and Reactivity of an Asymmetric Synthetic Mimic of Nitrogenase Cofactor.
- Published in:
- Angewandte Chemie International Edition, 2016, v. 55, n. 50, p. 15633, doi. 10.1002/anie.201608806
- By:
- Publication type:
- Article
Immunotherapy for Uterine Cervical Cancer Using Checkpoint Inhibitors: Future Directions.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 7, p. 2335, doi. 10.3390/ijms21072335
- By:
- Publication type:
- Article
Comparison of treatment outcomes between first-line chemotherapy with or without bevacizumab for advanced ovarian, fallopian tube, and primary peritoneal cancer (Tohoku gynecologic cancer unit: TGCU-RS001 study).
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 12, p. 1874, doi. 10.1007/s10147-022-02246-1
- By:
- Publication type:
- Article
Phase II clinical study of neoadjuvant chemotherapy with CDDP/CPT-11 regimen in combination with radical hysterectomy for cervical cancer with a bulky mass.
- Published in:
- International Journal of Clinical Oncology, 2016, v. 21, n. 6, p. 1120, doi. 10.1007/s10147-016-1008-7
- By:
- Publication type:
- Article
A New Therapeutic Strategy for Recurrent Ovarian Cancer―Bevacizumab beyond Progressive Disease.
- Published in:
- Healthcare (2227-9032), 2019, v. 7, n. 3, p. 109, doi. 10.3390/healthcare7030109
- By:
- Publication type:
- Article
Immunotherapy for Uterine Cervical Cancer.
- Published in:
- Healthcare (2227-9032), 2019, v. 7, n. 3, p. 108, doi. 10.3390/healthcare7030108
- By:
- Publication type:
- Article
Antibody-Drug Conjugates: The New Treatment Approaches for Ovarian Cancer.
- Published in:
- Cancers, 2024, v. 16, n. 14, p. 2545, doi. 10.3390/cancers16142545
- By:
- Publication type:
- Article
A Phase II Study of S-1 plus Oxaliplatin for Patients with Recurrent Non-Squamous Cell Carcinoma of the Uterine Cervix (Tohoku Gynecologic Cancer Unit: TGCU206 Study).
- Published in:
- Cancers, 2023, v. 15, n. 21, p. 5201, doi. 10.3390/cancers15215201
- By:
- Publication type:
- Article
Novel Therapeutic Strategies for Refractory Ovarian Cancers: Clear Cell and Mucinous Carcinomas.
- Published in:
- Cancers, 2021, v. 13, n. 23, p. 6120, doi. 10.3390/cancers13236120
- By:
- Publication type:
- Article
Incorporation of an Asymmetric Mo−Fe−S Cluster as an Artificial Cofactor into Nitrogenase.
- Published in:
- ChemBioChem, 2022, v. 23, n. 19, p. 1, doi. 10.1002/cbic.202200384
- By:
- Publication type:
- Article
A survey of carboplatin desensitization therapy in Japan: A multicenter retrospective study.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 5, p. 1, doi. 10.1002/cam4.6968
- By:
- Publication type:
- Article
Expression of human telomerase reverse transcriptase and correlation with telomerase activity in placentas with and without intrauterine growth retardation.
- Published in:
- 2006
- By:
- Publication type:
- journal article
A phase II clinical trial of palonosetron for the management of delayed vomiting in gynecological cancer patients receiving paclitaxel/carboplatin therapy.
- Published in:
- Molecular & Clinical Oncology, 2015, v. 3, n. 2, p. 281, doi. 10.3892/mco.2015.484
- By:
- Publication type:
- Article
Genome-wide analysis of microRNA to evaluate prognostic markers in isolated cancer glands and surrounding stroma in high-grade serous ovarian carcinoma.
- Published in:
- Oncology Letters, 2020, v. 20, n. 6, p. N.PAG, doi. 10.3892/ol.2020.12198
- By:
- Publication type:
- Article
A retrospective study of neoadjuvant chemotherapy plus radical hysterectomy versus radical hysterectomy alone in patients with stage II cervical squamous cell carcinoma presenting as a bulky mass.
- Published in:
- OncoTargets & Therapy, 2016, v. 9, p. 5651, doi. 10.2147/OTT.S101146
- By:
- Publication type:
- Article
A recurrent ovarian cancer patient with a history of nine prior chemotherapy regimens who was safely treated with weekly paclitaxel plus bevacizumab and achieved a complete response: a case report.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
Comparison of Postoperative Adjuvant Chemotherapy and Concurrent Chemoradiotherapy for FIGO2018 Stage IIIC1 Cervical Cancer: A Retrospective Study.
- Published in:
- Medicina (1010660X), 2021, v. 57, n. 6, p. 1, doi. 10.3390/medicina57060548
- By:
- Publication type:
- Article
Adjuvant Chemotherapy for Endometrial Cancer (ACE) trial: A randomized phase II study for advanced endometrial carcinoma.
- Published in:
- Cancer Science, 2022, v. 113, n. 5, p. 1693, doi. 10.1111/cas.15310
- By:
- Publication type:
- Article
Efficacy and safety of standard of care with/without bevacizumab for platinum‐resistant ovarian/fallopian tube/peritoneal cancer previously treated with bevacizumab: The Japanese Gynecologic Oncology Group study JGOG3023.
- Published in:
- Cancer Science, 2022, v. 113, n. 1, p. 240, doi. 10.1111/cas.15185
- By:
- Publication type:
- Article
Phase 1 study of veliparib with carboplatin and weekly paclitaxel in Japanese patients with newly diagnosed ovarian cancer.
- Published in:
- Cancer Science, 2017, v. 108, n. 11, p. 2213, doi. 10.1111/cas.13381
- By:
- Publication type:
- Article